Faculty

Institute Faculty | Affiliated Faculty

David Holtgrave, PhD

Professor and Chair
Department of Health, Behavior and Society
Johns Hopkins Bloomberg School of Public Health

Dr. Holtgrave's research has focused on the effectiveness and cost-effectiveness of a variety of HIV prevention interventions, and the relationship of the findings of these studies to HIV prevention policy making.  He has also investigated the relationship between social capital measures, infectious disease rates, and risk behavior prevalence. He has worked extensively on HIV prevention community planning. Dr. Holtgrave has recently begun to examine the cost-effectiveness of mass media approaches to the prevention of tobacco use.

Frances Stillman, EdD, EdM

Dr. Stillman is a clinical psychologist with over 18 years experience in tobacco control. She has published over 40 articles in more than 20 different journals. Her primary research focus has been on designing, implementing, and evaluating tobacco control and smoking cessation programs. She directed the implementation and evaluation of the project to create a Smoke-Free Johns Hopkins Hospital, which has served as a model for other hospitals across the U.S. Dr. Stillman has extensive experience working in tobacco control at the local, state, national and international levels. Before joining Johns Hopkins, Dr. Stillman directed the evaluation of the largest federally funded tobacco control effort, entitled "The American Stop Smoking Intervention Study (ASSIST)." She was responsible for developing the conceptual framework that guided this large-scale effort. Dr. Stillman has also been involved with community participatory research and mobilization projects and has conducted and evaluated clinical trials of smoking cessation efforts.

Erika Avila-Tang, PhD, MHS

Dr. Avila-Tang is a project coordinator at the Institute for Global Tobacco Control. Dr. Avila-Tang’s experience includes the development, management, review of articles, data abstraction, and quality control of literature databases in support of the 2004 Surgeon General’s Report on active smoking, the 2006 Surgeon General’s Report on involuntary smoking, and the 2003 Tobacco*Free Japan report. Dr. Tang also authored a key comprehensive review chapter on the epidemiology of asthma and allergic disease for Allergy Principles and Practice, a prestigious medical textbook. She is currently working in research projects on tobacco control to produce evidence for policy development and capacity building.

Stephen Tamplin, MSE

Mr. Tamplin is an Associate Scientist in the Department of Health, Behavior, and Society. He has served in the past as a private consultant on environment, health and development issues and his clients have included the JHSPH Institute for Global Tobacco Control, the World Health Organization, the U.K. Department for International Development, the United Nations Children’s Fund and the University of Western Sydney, Australia.  His professional career has included long-term assignments with the World Health Organization (18 years in the Western Pacific Region where he served as the Regional Focal Point for Tobacco Control from 1998-2002), the Illinois Environmental Protection Agency (12 years) and the West Virginia Air Pollution Control Commission 4 years).  He has broad-based public health and environment experience in the United States and in Asia and the Pacific covering a range of technical disciplines, including tobacco control, air and water pollution control, chemical safety and hazardous waste management, and health promotion.

Benjamin Apelberg, PhD, MHS

Dr. Apelberg is an Assistant Scientist in the Department of Epidemiology.  He is an environmental epidemiologist with research experience in the investigation of the health impacts of environmental pollutants, including tobacco.  Dr. Apelberg has also conducted several analyses on the projected population health benefits associated with increasing rates of smoking cessation, both in the U.S. and Japan.  He is currently working on the development of an individualized risk prediction tool for estimating smokers’ risk for developing disease.